HUGE.CN - FSD Pharma Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 5151.6M
Enterprise Value 3145.07M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2,687.58
Price/Book (mrq)2.16
Enterprise Value/Revenue 32,571.79
Enterprise Value/EBITDA 6-5.47

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-88.89%
S&P500 52-Week Change 32.59%
52 Week High 30.9000
52 Week Low 30.0900
50-Day Moving Average 30.1076
200-Day Moving Average 30.1813

Share Statistics

Avg Vol (3 month) 32.1M
Avg Vol (10 day) 31.3M
Shares Outstanding 51.52B
Float 1.39B
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Aug 15, 2019) 4274.73k
Short Ratio (Aug 15, 2019) 40.18
Short % of Float (Aug 15, 2019) 4N/A
Short % of Shares Outstanding (Aug 15, 2019) 40.02%
Shares Short (prior month Jul 15, 2019) 4589.85k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-47,658.20%

Management Effectiveness

Return on Assets (ttm)-27.04%
Return on Equity (ttm)-56.24%

Income Statement

Revenue (ttm)56.41k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-37.00%
Gross Profit (ttm)-313.13k
EBITDA -26.5M
Net Income Avi to Common (ttm)-33.58M
Diluted EPS (ttm)-0.0220
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.84M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)2.15M
Total Debt/Equity (mrq)3.20
Current Ratio (mrq)3.19
Book Value Per Share (mrq)0.04

Cash Flow Statement

Operating Cash Flow (ttm)-25.53M
Levered Free Cash Flow (ttm)-851.16k